APA (7th ed.) Citation

Sally C.M. Lau, M., Malcolm Ryan, B., Jessica Weiss, P., Aline Fusco Fares, M., Miguel Garcia, M., Sabine Schmid, M., . . . Adrian G. Sacher, M. (2021, December). Concurrent Chemoradiation With or Without Durvalumab in Elderly Patients With Unresectable Stage III NSCLC: Safety and Efficacy. JTO Clinical and Research Reports.

Chicago Style (17th ed.) Citation

Sally C.M. Lau, MD, et al. "Concurrent Chemoradiation With or Without Durvalumab in Elderly Patients With Unresectable Stage III NSCLC: Safety and Efficacy." JTO Clinical and Research Reports Dec. 2021.

MLA (9th ed.) Citation

Sally C.M. Lau, MD, et al. "Concurrent Chemoradiation With or Without Durvalumab in Elderly Patients With Unresectable Stage III NSCLC: Safety and Efficacy." JTO Clinical and Research Reports, Dec. 2021.